Pharmaco - Press Releases

Date	Title	Company
25-Jul-2023	Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.	Johnson & Johnson
25-Jul-2023	Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias	Johnson & Johnson
25-Jul-2023	Twice-Yearly Lenacapavir Demonstrates Sustained Impact on Health-Related Quality of Life in People With HIV	Gilead
25-Jul-2023	Baxter Launches PERCLOT Absorbable Hemostatic Powder	Baxter
25-Jul-2023	Medartis 2023 half-year results presentation	Medartis Holding AG
25-Jul-2023	BioMap unveils a "Life Science Leaderboard" to compare AI models and reveals the advanced capabilities of its 100B-scale "xTrimo" model	Sciad Newswire
25-Jul-2023	Evolva receives approval for Veri-teTM Resveratrol in Taiwan	Evolva Holding SA
24-Jul-2023	Bayer Aktiengesellschaft: Bayer lowers full-year outlook	Bayer Aktiengesellschaft
24-Jul-2023	Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets	Epigenomics AG
24-Jul-2023	Epigenomics AG: Agreement on the Acquisition of Almost All Assets	Epigenomics AG
24-Jul-2023	Polpharma Biologics Announces First-of-a-Kind Multiple Sclerosis Biosimilar Natalizumab Receives Positive CHMP Opinion	B3C newswire
22-Jul-2023	27th International Conference on Advanced Nanoscience and Nanotechnology	Allied Academies
21-Jul-2023	No resolution on certain capital measures at the Annual General Meeting	aap Implantate AG
21-Jul-2023	Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.	Eckert & Ziegler Strahlen- und Medizintechnik AG
21-Jul-2023	Toppan Holds VIRTUAL REMIX JAPAN™ Metaverse Event	Toppan
21-Jul-2023	Are shared medical appointments the key to solving global healthcare shortages?	ESMT Berlin
21-Jul-2023	Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company	Sosei Group Corporation
21-Jul-2023	The Science-Based Targets Initiative (SBTi) validates Almirall's 2030 emission reduction targets and its goal of achieving net zero emissions by 2050	Almirall
21-Jul-2023	Teva UK launches GoResp® Digihaler® (budesonide/ formoterol), the first integrated digital inhaler system for appropriate adult patients with asthma and COPD[i] in the UK	Teva UK Limited
21-Jul-2023	Researchers aim for rapid biomarker diagnostic test for stroke, using saliva	University of Birmingham